ADAMS STREET PARTNERS LLC

Holdings History for Corvus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (CRVS)

Symbol: CRVS on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Shares Owned: 3,275,616 shares
Security Ownership %: 3.9%

Shares, Excluding Options vs Price

Value, Excluding Options

Adams Street Partners, LLC ownership in Corvus Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (CRVS)

05 Feb 2026 - Adams Street Partners, LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,275,616 shares of Corvus Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (CRVS). This represents 3.9% ownership of the company. This is the first filing by ADAMS STREET PARTNERS LLC disclosing ownership of Corvus Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (CRVS).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Adams Street Partners, LLC	3.9%		$25,222,243	3,275,616			$7.70	13D/A	23 Jan 2026	05 Feb 2026, 10:29

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	9.6%	0%	$25,222,243	3,275,616	0		$7.70	Q4 2025
30 Sep 2025	16%	0%	$24,141,290	3,275,616	0		$7.37	Q3 2025
30 Jun 2025	9.2%	0%	$13,102,464	3,275,616	0		$4.00	Q2 2025
31 Mar 2025	9.2%	0%	$10,416,459	3,275,616	0		$3.18	Q1 2025
31 Dec 2024	16%	0%	$17,524,546	3,275,616	0		$5.35	Q4 2024
30 Sep 2024	9.5%	0%	$17,295,252	3,275,616	0		$5.28	Q3 2024
30 Jun 2024	2.5%	0%	$5,961,621	3,275,616	0		$1.82	Q2 2024
31 Mar 2024	2.3%	0%	$5,830,596	3,275,616	0		$1.78	Q1 2024
31 Dec 2023	1.8%	0%	$5,765,084	3,275,616	0		$1.76	Q4 2023
30 Sep 2023	1.8%	0%	$4,782,399	3,275,616	0		$1.46	Q3 2023
30 Jun 2023	2%	0%	$7,501,161	3,275,616	0		$2.29	Q2 2023
31 Mar 2023	0.93%	0%	$2,980,811	3,275,616	0		$0.91	Q1 2023
31 Dec 2022	0.93%	0%	$2,784,274	3,275,616	0		$0.85	Q4 2022
30 Sep 2022	0.73%	0%	$2,683,000	3,275,616	0		$0.82	Q3 2022
30 Jun 2022	0.84%	0%	$3,243,000	3,275,616	0		$0.99	Q2 2022
31 Mar 2022	0.99%	0%	$5,373,000	3,275,616	0		$1.64	Q1 2022
31 Dec 2021	1.2%	0%	$7,894,000	3,275,616	0		$2.41	Q4 2021
30 Sep 2021	2%	0%	$15,854,000	3,275,616	0		$4.84	Q3 2021
30 Jun 2021	1.8%	0%	$8,746,000	3,275,616	0		$2.67	Q2 2021
31 Mar 2021	1.6%	0%	$10,089,000	3,275,616	0		$3.08	Q1 2021
31 Dec 2020	2.4%	0%	$11,661,000	3,275,616	0		$3.56	Q4 2020
30 Sep 2020	3.5%	0%	$13,135,000	3,275,616	0		$4.01	Q3 2020
30 Jun 2020	1.8%	0%	$8,910,000	3,275,616	0		$2.72	Q2 2020
31 Mar 2020	1.7%	0%	$6,912,000	3,275,616	0		$2.11	Q1 2020
31 Dec 2019	3.6%	0%	$17,819,000	3,275,616	0		$5.44	Q4 2019
30 Sep 2019	2%	0%	$9,860,000	3,275,616	0		$3.01	Q3 2019
30 Jun 2019	2.3%	0%	$12,251,000	3,275,616	0		$3.74	Q2 2019
31 Mar 2019	2.5%	0%	$13,168,000	3,275,616	0		$4.02	Q1 2019
31 Dec 2018	2.5%	0%	$12,022,000	3,275,616	0		$3.67	Q4 2018
30 Sep 2018	4.4%	0%	$28,105,000	3,275,616	0		$8.58	Q3 2018
30 Jun 2018	5.5%	0%	$35,966,000	3,275,616	0		$10.98	Q2 2018
31 Mar 2018	9.1%	+1.6%	$33,991,000	3,275,616	+588,235	+22%	$10.38	Q1 2018
31 Dec 2017	6.6%	0%	$27,841,000	2,687,381	0		$10.36	Q4 2017
30 Sep 2017	11%	0%	$42,837,000	2,687,381	0		$15.94	Q3 2017
30 Jun 2017	7.6%	0%	$32,517,000	2,687,381	0		$12.10	Q2 2017
31 Mar 2017	14%	0%	$55,817,000	2,687,381	0		$20.77	Q1 2017
31 Dec 2016	11%	0%	$38,430,000	2,687,381	0		$14.30	Q4 2016
30 Sep 2016	8.3%	0%	$44,207,000	2,687,381	0		$16.45	Q3 2016
30 Jun 2016		0%	$28,742,000	2,687,381	0		$10.70 ^*	Q2 2016
31 Mar 2016		0%	$29,225,000	2,687,381	0		$10.87 ^*	Q1 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.